ondansetron has been researched along with Ataxia in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to learn whether the lethal and the motor incoordination (ataxia) side effect of ondansetron (Zophren) administration is dosing-time dependent." | 3.72 | Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice. ( Ben Attia, M; Boughattas, NA; Bouzouita, K; Chouchane, L; Gadacha, W; Khedhaier, A; Mechkouri, M; Reinberg, A; Sani, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khedhaier, A | 1 |
| Ben Attia, M | 1 |
| Gadacha, W | 1 |
| Sani, M | 1 |
| Bouzouita, K | 1 |
| Chouchane, L | 1 |
| Mechkouri, M | 1 |
| Reinberg, A | 1 |
| Boughattas, NA | 1 |
1 other study available for ondansetron and Ataxia
| Article | Year |
|---|---|
Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice.
Topics: Animals; Ataxia; Body Temperature; Body Weight; Circadian Rhythm; Humans; Male; Mice; Ondansetron; R | 2003 |